Cite
Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
MLA
Tao P Wu, et al. “Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.” OncoTargets and Therapy, vol. 13, Dec. 2020, pp. 12683–93. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....80d79b03a8c28a8dd9f21d10862c9502&authtype=sso&custid=ns315887.
APA
Tao P Wu, Mian Chen, Mengya Zang, Wei Huang, Wenxuan Yu, Xiao Cheng, Jinzhang Chen, Xiaoyun Hu, Jian Ruan, Wenzhe Fan, Qi Rong Li, Wencong Dai, Yabing Guo, & Guosheng Yuan. (2020). Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. OncoTargets and Therapy, 13, 12683–12693.
Chicago
Tao P Wu, Mian Chen, Mengya Zang, Wei Huang, Wenxuan Yu, Xiao Cheng, Jinzhang Chen, et al. 2020. “Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.” OncoTargets and Therapy 13 (December): 12683–93. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....80d79b03a8c28a8dd9f21d10862c9502&authtype=sso&custid=ns315887.